Timeline of Lilly’s outsourcing

By Nick Taylor

- Last updated on GMT

Related tags: Param name=, Pharmacology

Timeline of Lilly’s outsourcing
Eli Lilly has taken an expansive approach to outsourcing, adding an agreement with Thermo Fisher to its raft of deals, and this strategy is visualised in an interactive timeline from Outsourcing-Pharma.

Since committing to an outsourcing strategy in December 2007 the big pharma has inked a number of deals spanning clinical trials, active pharmaceutical ingredients (API) and drug discovery.

This strategy, which is among the most expansive in the industry, is visualised below. Move the mouse over an area to show headlines and click on the text bubbles to bring up further information and a link to the complete article.

Related news

Show more

Related products

show more


Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.


Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

Related suppliers